DermTech (NASDAQ:DMTK – Get Rating) is scheduled to be releasing its earnings data after the market closes on Tuesday, May 3rd. Analysts expect DermTech to post earnings of ($0.85) per share for the quarter. DermTech (NASDAQ:DMTK – Get Rating) last posted its quarterly earnings data on Tuesday, March 1st. The company reported ($0.88) earnings per […]
Stock Market | Daily Herald dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.
DermTech (NASDAQ:DMTK – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Thursday, Zacks.com reports. According to Zacks, “DermTech Inc. markets and develops products which facilitate early detection of skin cancers, assess inflammatory diseases and customize drug treatments. DermTech Inc., formerly known […]
Aiming to help people bypass a biopsy, La Jolla company DermTech has developed a skin patch to test for melanoma using genomics, or the study of a person’s genes.
DermTech (NASDAQ:DMTK – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Monday, Zacks.com reports. According to Zacks, “DermTech Inc. markets and develops products which facilitate early detection of skin cancers, assess inflammatory diseases and customize drug treatments. DermTech Inc., formerly known as […]